200 related articles for article (PubMed ID: 25373630)
1. A single-dose pilot trial of intranasal rapid-acting insulin in apolipoprotein E4 carriers with mild-moderate Alzheimer's disease.
Rosenbloom MH; Barclay TR; Pyle M; Owens BL; Cagan AB; Anderson CP; Frey WH; Hanson LR
CNS Drugs; 2014 Dec; 28(12):1185-9. PubMed ID: 25373630
[TBL] [Abstract][Full Text] [Related]
2. A Phase II, Single-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Therapeutic Efficacy of Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease.
Rosenbloom M; Barclay TR; Kashyap B; Hage L; O'Keefe LR; Svitak A; Pyle M; Frey W; Hanson LR
Drugs Aging; 2021 May; 38(5):407-415. PubMed ID: 33719017
[TBL] [Abstract][Full Text] [Related]
3. Long-acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimer's disease dementia.
Claxton A; Baker LD; Hanson A; Trittschuh EH; Cholerton B; Morgan A; Callaghan M; Arbuckle M; Behl C; Craft S
J Alzheimers Dis; 2015; 44(3):897-906. PubMed ID: 25374101
[TBL] [Abstract][Full Text] [Related]
4. Effects of Regular and Long-Acting Insulin on Cognition and Alzheimer's Disease Biomarkers: A Pilot Clinical Trial.
Craft S; Claxton A; Baker LD; Hanson AJ; Cholerton B; Trittschuh EH; Dahl D; Caulder E; Neth B; Montine TJ; Jung Y; Maldjian J; Whitlow C; Friedman S
J Alzheimers Dis; 2017; 57(4):1325-1334. PubMed ID: 28372335
[TBL] [Abstract][Full Text] [Related]
5. Clinical Effects of Tramiprosate in APOE4/4 Homozygous Patients with Mild Alzheimer's Disease Suggest Disease Modification Potential.
Abushakra S; Porsteinsson A; Scheltens P; Sadowsky C; Vellas B; Cummings J; Gauthier S; Hey JA; Power A; Wang P; Shen L; Tolar M
J Prev Alzheimers Dis; 2017; 4(3):149-156. PubMed ID: 29182706
[TBL] [Abstract][Full Text] [Related]
6. In Thai Nationals, the ApoE4 Allele Affects Multiple Domains of Neuropsychological, Biobehavioral, and Social Functioning Thereby Contributing to Alzheimer's Disorder, while the ApoE3 Allele Protects Against Neuropsychiatric Symptoms and Psychosocial Deficits.
Tangwongchai S; Supasitthumrong T; Hemrunroj S; Tunvirachaisakul C; Chuchuen P; Houngngam N; Snabboon T; Tawankanjanachot I; Likitchareon Y; Phanthumchindad K; Maes M
Mol Neurobiol; 2018 Aug; 55(8):6449-6462. PubMed ID: 29307083
[TBL] [Abstract][Full Text] [Related]
7. Medium-chain triglycerides improved cognition and lipid metabolomics in mild to moderate Alzheimer's disease patients with APOE4
Xu Q; Zhang Y; Zhang X; Liu L; Zhou B; Mo R; Li Y; Li H; Li F; Tao Y; Liu Y; Xue C
Clin Nutr; 2020 Jul; 39(7):2092-2105. PubMed ID: 31694759
[TBL] [Abstract][Full Text] [Related]
8. Peripheral Blood Biomarkers Coupled with the Apolipoprotein E4 Genotype Are Strongly Associated with Semantic and Episodic Memory Impairments in Elderly Subjects with Amnestic Mild Cognitive Impairment and Alzheimer's Disease.
Supasitthumrong T; Tunvirachaisakul C; Aniwattanapong D; Tangwongchai S; Chuchuen P; Tawankanjanachot I; Snabboon T; Hemrungrojn S; Carvalho AF; Maes M
J Alzheimers Dis; 2019; 71(3):797-811. PubMed ID: 31424390
[TBL] [Abstract][Full Text] [Related]
9. Effect of Apolipoprotein E4 on the Driving Behavior of Patients with Amnestic Mild Cognitive Impairment or Mild Alzheimer's Disease Dementia.
Stanitsa E; Economou A; Beratis I; Kontaxopoulou D; Fragkiadaki S; Papastefanopoulou V; Pavlou D; Papantoniou P; Kroupis C; Papatriantafyllou J; Stefanis L; Yannis G; Papageorgiou SG
J Alzheimers Dis; 2021; 84(3):1005-1014. PubMed ID: 34602476
[TBL] [Abstract][Full Text] [Related]
10. Severity-Related Increase and Cognitive Correlates of Serum VEGF Levels in Alzheimer's Disease ApoE4 Carriers.
Alvarez XA; Alvarez I; Aleixandre M; Linares C; Muresanu D; Winter S; Moessler H
J Alzheimers Dis; 2018; 63(3):1003-1013. PubMed ID: 29710700
[TBL] [Abstract][Full Text] [Related]
11. Apathy and APOE4 are associated with reduced BDNF levels in Alzheimer's disease.
Alvarez A; Aleixandre M; Linares C; Masliah E; Moessler H
J Alzheimers Dis; 2014; 42(4):1347-55. PubMed ID: 25024337
[TBL] [Abstract][Full Text] [Related]
12. Impaired memory-guided attention in asymptomatic APOE4 carriers.
Zimmermann J; Alain C; Butler C
Sci Rep; 2019 May; 9(1):8138. PubMed ID: 31148578
[TBL] [Abstract][Full Text] [Related]
13. Association of Asymmetrical White Matter Hyperintensities and Apolipoprotein E4 on Cognitive Impairment.
Low A; Ng KP; Chander RJ; Wong B; Kandiah N
J Alzheimers Dis; 2019; 70(3):953-964. PubMed ID: 31306121
[TBL] [Abstract][Full Text] [Related]
14. Double-Blind Placebo-Controlled Pilot Investigation of the Safety of a Single Dose of Rapid-Acting Intranasal Insulin in Down Syndrome.
Rosenbloom M; Barclay T; Johnsen J; Erickson L; Svitak A; Pyle M; Frey W; Hanson LR
Drugs R D; 2020 Mar; 20(1):11-15. PubMed ID: 32077057
[TBL] [Abstract][Full Text] [Related]
15. Sex and ApoE genotype differences in treatment response to two doses of intranasal insulin in adults with mild cognitive impairment or Alzheimer's disease.
Claxton A; Baker LD; Wilkinson CW; Trittschuh EH; Chapman D; Watson GS; Cholerton B; Plymate SR; Arbuckle M; Craft S
J Alzheimers Dis; 2013; 35(4):789-97. PubMed ID: 23507773
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin converting enzyme inhibitors and Alzheimer disease in the presence of the apolipoprotein E4 allele.
Qiu WW; Lai A; Mon T; Mwamburi M; Taylor W; Rosenzweig J; Kowall N; Stern R; Zhu H; Steffens DC
Am J Geriatr Psychiatry; 2014 Feb; 22(2):177-85. PubMed ID: 23567418
[TBL] [Abstract][Full Text] [Related]
17. Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
Mandecka M; Budziszewska M; Barczak A; Pepłońska B; Chodakowska-Żebrowska M; Filipek-Gliszczyńska A; Nesteruk M; Styczyńska M; Barcikowska M; Gabryelewicz T
J Alzheimers Dis; 2016 Jul; 54(1):157-68. PubMed ID: 27472875
[TBL] [Abstract][Full Text] [Related]
18. The Impact of APOE ɛ4 in Alzheimer's Disease Differs According to Age.
Kim J; Park S; Yoo H; Jang H; Kim Y; Kim KW; Jang YK; Lee JS; Kim ST; Kim S; Lee JM; Ki CS; Na DL; Seo SW; Kim HJ
J Alzheimers Dis; 2018; 61(4):1377-1385. PubMed ID: 29376853
[TBL] [Abstract][Full Text] [Related]
19. Effects of LDL Cholesterol and Statin Use on Verbal Learning and Memory in Older Adults at Genetic Risk for Alzheimer's Disease.
Wroolie T; Roat-Shumway S; Watson K; Reiman E; Rasgon N
J Alzheimers Dis; 2020; 75(3):903-910. PubMed ID: 32390619
[TBL] [Abstract][Full Text] [Related]
20. Neuroimaging biomarkers for Alzheimer's disease in asymptomatic APOE4 carriers.
Chételat G; Fouquet M
Rev Neurol (Paris); 2013 Oct; 169(10):729-36. PubMed ID: 24016463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
